| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 12 |
| GO:0043226 | organelle | 2 | 12 |
| GO:0043227 | membrane-bounded organelle | 3 | 12 |
| GO:0043229 | intracellular organelle | 3 | 12 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
| GO:0110165 | cellular anatomical entity | 1 | 12 |
| GO:0030896 | checkpoint clamp complex | 3 | 1 |
| GO:0032991 | protein-containing complex | 1 | 1 |
| GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A4HYN1
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000075 | cell cycle checkpoint signaling | 4 | 12 |
| GO:0000077 | DNA damage checkpoint signaling | 5 | 12 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
| GO:0006259 | DNA metabolic process | 4 | 12 |
| GO:0006281 | DNA repair | 5 | 12 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
| GO:0006950 | response to stress | 2 | 12 |
| GO:0006974 | DNA damage response | 4 | 12 |
| GO:0007165 | signal transduction | 2 | 12 |
| GO:0008152 | metabolic process | 1 | 12 |
| GO:0009987 | cellular process | 1 | 12 |
| GO:0010564 | regulation of cell cycle process | 5 | 12 |
| GO:0010948 | negative regulation of cell cycle process | 6 | 12 |
| GO:0031570 | DNA integrity checkpoint signaling | 5 | 12 |
| GO:0033554 | cellular response to stress | 3 | 12 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
| GO:0035556 | intracellular signal transduction | 3 | 12 |
| GO:0042770 | signal transduction in response to DNA damage | 4 | 12 |
| GO:0043170 | macromolecule metabolic process | 3 | 12 |
| GO:0044237 | cellular metabolic process | 2 | 12 |
| GO:0044238 | primary metabolic process | 2 | 12 |
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
| GO:0045786 | negative regulation of cell cycle | 5 | 12 |
| GO:0046483 | heterocycle metabolic process | 3 | 12 |
| GO:0048519 | negative regulation of biological process | 3 | 12 |
| GO:0048523 | negative regulation of cellular process | 4 | 12 |
| GO:0050789 | regulation of biological process | 2 | 12 |
| GO:0050794 | regulation of cellular process | 3 | 12 |
| GO:0050896 | response to stimulus | 1 | 12 |
| GO:0051716 | cellular response to stimulus | 2 | 12 |
| GO:0051726 | regulation of cell cycle | 4 | 12 |
| GO:0065007 | biological regulation | 1 | 12 |
| GO:0071704 | organic substance metabolic process | 2 | 12 |
| GO:0090304 | nucleic acid metabolic process | 4 | 12 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
| GO:1901987 | regulation of cell cycle phase transition | 6 | 12 |
| GO:1901988 | negative regulation of cell cycle phase transition | 7 | 12 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 1 |
| GO:0004518 | nuclease activity | 4 | 1 |
| GO:0004527 | exonuclease activity | 5 | 1 |
| GO:0004529 | DNA exonuclease activity | 5 | 1 |
| GO:0004536 | DNA nuclease activity | 4 | 1 |
| GO:0008853 | obsolete exodeoxyribonuclease III activity | 7 | 1 |
| GO:0016787 | hydrolase activity | 2 | 1 |
| GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
| GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
| GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
| GO:0140097 | catalytic activity, acting on DNA | 3 | 1 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 75 | 79 | PF00656 | 0.349 |
| CLV_MEL_PAP_1 | 157 | 163 | PF00089 | 0.452 |
| CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.387 |
| CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.399 |
| CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.457 |
| DEG_APCC_DBOX_1 | 152 | 160 | PF00400 | 0.461 |
| DOC_CYCLIN_RxL_1 | 53 | 61 | PF00134 | 0.447 |
| DOC_MAPK_gen_1 | 150 | 159 | PF00069 | 0.418 |
| DOC_MAPK_HePTP_8 | 192 | 204 | PF00069 | 0.406 |
| DOC_MAPK_MEF2A_6 | 153 | 161 | PF00069 | 0.432 |
| DOC_MAPK_MEF2A_6 | 195 | 204 | PF00069 | 0.500 |
| DOC_MAPK_MEF2A_6 | 6 | 14 | PF00069 | 0.362 |
| DOC_PP2B_LxvP_1 | 71 | 74 | PF13499 | 0.425 |
| DOC_USP7_MATH_1 | 190 | 194 | PF00917 | 0.451 |
| DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.486 |
| DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.508 |
| DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.473 |
| LIG_14-3-3_CanoR_1 | 141 | 147 | PF00244 | 0.521 |
| LIG_14-3-3_CanoR_1 | 15 | 21 | PF00244 | 0.517 |
| LIG_14-3-3_CanoR_1 | 160 | 167 | PF00244 | 0.542 |
| LIG_14-3-3_CanoR_1 | 237 | 245 | PF00244 | 0.394 |
| LIG_Actin_WH2_2 | 145 | 162 | PF00022 | 0.525 |
| LIG_APCC_ABBA_1 | 37 | 42 | PF00400 | 0.367 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.333 |
| LIG_deltaCOP1_diTrp_1 | 25 | 32 | PF00928 | 0.329 |
| LIG_FHA_1 | 110 | 116 | PF00498 | 0.457 |
| LIG_FHA_1 | 147 | 153 | PF00498 | 0.407 |
| LIG_FHA_1 | 17 | 23 | PF00498 | 0.414 |
| LIG_FHA_1 | 238 | 244 | PF00498 | 0.421 |
| LIG_FHA_1 | 49 | 55 | PF00498 | 0.384 |
| LIG_FHA_1 | 90 | 96 | PF00498 | 0.433 |
| LIG_FHA_2 | 108 | 114 | PF00498 | 0.439 |
| LIG_FHA_2 | 129 | 135 | PF00498 | 0.673 |
| LIG_FHA_2 | 174 | 180 | PF00498 | 0.405 |
| LIG_FHA_2 | 73 | 79 | PF00498 | 0.391 |
| LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.358 |
| LIG_LIR_Gen_1 | 25 | 32 | PF02991 | 0.344 |
| LIG_LIR_Gen_1 | 61 | 70 | PF02991 | 0.481 |
| LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.342 |
| LIG_LIR_Nem_3 | 25 | 30 | PF02991 | 0.390 |
| LIG_LIR_Nem_3 | 61 | 65 | PF02991 | 0.423 |
| LIG_NRBOX | 142 | 148 | PF00104 | 0.511 |
| LIG_SH2_CRK | 4 | 8 | PF00017 | 0.355 |
| LIG_SH2_NCK_1 | 62 | 66 | PF00017 | 0.492 |
| LIG_SH2_STAP1 | 239 | 243 | PF00017 | 0.503 |
| LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.513 |
| LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.342 |
| LIG_SUMO_SIM_par_1 | 105 | 110 | PF11976 | 0.340 |
| LIG_SUMO_SIM_par_1 | 18 | 23 | PF11976 | 0.411 |
| LIG_SUMO_SIM_par_1 | 221 | 229 | PF11976 | 0.538 |
| MOD_CDK_SPxxK_3 | 107 | 114 | PF00069 | 0.466 |
| MOD_CK1_1 | 233 | 239 | PF00069 | 0.426 |
| MOD_CK1_1 | 86 | 92 | PF00069 | 0.549 |
| MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.559 |
| MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.389 |
| MOD_GlcNHglycan | 231 | 235 | PF01048 | 0.545 |
| MOD_GSK3_1 | 142 | 149 | PF00069 | 0.421 |
| MOD_GSK3_1 | 16 | 23 | PF00069 | 0.411 |
| MOD_GSK3_1 | 226 | 233 | PF00069 | 0.535 |
| MOD_GSK3_1 | 26 | 33 | PF00069 | 0.295 |
| MOD_GSK3_1 | 46 | 53 | PF00069 | 0.417 |
| MOD_N-GLC_1 | 46 | 51 | PF02516 | 0.533 |
| MOD_NEK2_1 | 142 | 147 | PF00069 | 0.406 |
| MOD_NEK2_1 | 161 | 166 | PF00069 | 0.461 |
| MOD_NEK2_1 | 32 | 37 | PF00069 | 0.430 |
| MOD_NEK2_1 | 48 | 53 | PF00069 | 0.515 |
| MOD_NEK2_2 | 190 | 195 | PF00069 | 0.280 |
| MOD_PIKK_1 | 128 | 134 | PF00454 | 0.536 |
| MOD_PKA_2 | 159 | 165 | PF00069 | 0.540 |
| MOD_Plk_1 | 190 | 196 | PF00069 | 0.460 |
| MOD_Plk_4 | 142 | 148 | PF00069 | 0.481 |
| MOD_Plk_4 | 26 | 32 | PF00069 | 0.378 |
| MOD_Plk_4 | 72 | 78 | PF00069 | 0.412 |
| MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.522 |
| MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.477 |
| MOD_SUMO_rev_2 | 101 | 106 | PF00179 | 0.444 |
| MOD_SUMO_rev_2 | 191 | 200 | PF00179 | 0.412 |
| TRG_ENDOCYTIC_2 | 211 | 214 | PF00928 | 0.511 |
| TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.342 |
| TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.499 |
| TRG_Pf-PMV_PEXEL_1 | 104 | 108 | PF00026 | 0.341 |
| TRG_Pf-PMV_PEXEL_1 | 178 | 183 | PF00026 | 0.498 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HUB9 | Leptomonas seymouri | 73% | 71% |
| A0A0S4J1V0 | Bodo saltans | 35% | 83% |
| A0A1X0NWX4 | Trypanosomatidae | 47% | 81% |
| A0A3S7WVU5 | Leishmania donovani | 100% | 69% |
| A0A422NCM6 | Trypanosoma rangeli | 47% | 82% |
| C9ZI59 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 81% |
| E9AI98 | Leishmania braziliensis | 91% | 100% |
| E9AUI3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
| Q4QD01 | Leishmania major | 97% | 100% |
| V5BVI1 | Trypanosoma cruzi | 47% | 82% |